Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Telmisartan
Drug ID BADD_D02147
Description Telmisartan is an angiotensin II receptor antagonist (ARB) used in the management of hypertension. Generally, angiotensin II receptor blockers (ARBs) such as telmisartan bind to the angiotensin II type 1 (AT1) receptors with high affinity, causing inhibition of the action of angiotensin II on vascular smooth muscle, ultimately leading to a reduction in arterial blood pressure. Recent studies suggest that telmisartan may also have PPAR-gamma agonistic properties that could potentially confer beneficial metabolic effects.
Indications and Usage Used alone or in combination with other classes of antihypertensives for the treatment of hypertension. Also used in the treatment of diabetic nephropathy in hypertensive patients with type 2 diabetes mellitus, as well as the treatment of congestive heart failure (only in patients who cannot tolerate ACE inhibitors).
Marketing Status approved; investigational
ATC Code C09CA07
DrugBank ID DB00966
KEGG ID D00627
MeSH ID D000077333
PubChem ID 65999
TTD Drug ID D0N6RF
NDC Product Code 72606-506; 10695-139; 65841-805; 68462-199; 68462-200; 72606-507; 55111-095; 62135-536; 62135-537; 62332-089; 65162-293; 71209-049; 52286-0024; 53104-7624; 65404-007; 42291-792; 42571-226; 62135-535; 62332-087; 0597-0041; 72241-017; 65841-804; 65862-868; 68071-2591; 72241-015; 72241-016; 65372-1146; 42291-790; 46708-608; 53002-1794; 71335-1428; 71335-2173; 12666-0010; 50370-0015; 64220-124; 65862-727; 68554-0049; 42571-227; 43547-284; 43547-285; 53746-291; 63629-5682; 0378-2920; 67877-482; 68382-472; 68382-473; 70518-3556; 0597-0039; 65404-006; 66039-895; 71052-679; 45865-836; 53746-292; 65841-806; 65862-867; 68071-5178; 71335-1723; 57451-1206; 46708-610; 67877-483; 68788-8440; 68788-8441; 70518-3300; 0597-0040; 62512-0040; 64552-4026; 65015-845; 42291-791; 43547-283; 53746-293; 62332-088; 0378-2921; 65862-869; 67877-484; 68462-201; 70518-2572; 71209-050; 71209-051; 72606-508; 52562-009; 72761-021; 42571-228; 46708-609; 50090-5490; 63187-951; 0378-2922; 65162-291; 65162-292; 68382-471; 71335-2191; 62331-032; 64220-171
UNII U5SYW473RQ
Synonyms Telmisartan | 4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid | Pritor | BIBR 277 | BIBR-277 | Micardis
Chemical Information
Molecular Formula C33H30N4O2
CAS Registry Number 144701-48-4
SMILES CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Photosensitivity reaction23.03.09.0030.000963%
Plantar fasciitis15.03.03.002--Not Available
Pleural effusion22.05.02.0020.000390%
Pneumonia22.07.01.003; 11.01.09.003--Not Available
Pollakiuria20.02.02.0070.001093%
Premature baby18.04.02.0010.001041%Not Available
Premature delivery18.07.01.0060.000390%
Presyncope02.11.04.013; 24.06.02.010; 17.02.05.0090.000781%
Prostatism21.04.01.003; 20.02.03.0090.000521%Not Available
Proteinuria20.02.01.0110.000260%
Pruritus23.03.12.001--
Pulmonary fibrosis22.01.02.0060.000260%
Pulmonary oedema02.05.02.003; 22.01.03.0030.000260%
Purpura24.07.06.005; 23.06.01.004; 01.01.04.0030.000260%
Pyrexia08.05.02.0030.001952%
Rash23.03.13.001--Not Available
Rash pruritic23.03.13.0300.000260%Not Available
Rash scarlatiniform23.03.13.0060.000260%Not Available
Rectal haemorrhage24.07.02.018; 07.12.03.0010.000521%
Renal disorder20.01.02.0020.000390%Not Available
Renal failure20.01.03.0050.002603%Not Available
Renal tubular disorder20.05.03.0040.000260%Not Available
Renal vein thrombosis24.01.11.002; 20.01.07.0110.001171%Not Available
Respiratory alkalosis14.01.05.001; 22.02.02.005--Not Available
Respiratory distress22.02.01.012--Not Available
Restlessness19.11.02.002; 17.02.05.0210.000651%
Rhabdomyolysis15.05.05.0020.000781%
Rhinitis11.01.13.004; 22.07.03.006--
Sciatica17.10.03.001; 15.10.01.001--Not Available
Sepsis11.01.11.003--
The 9th Page    First    Pre   9 10 11 12 13    Next   Last    Total 14 Pages